ArticleDEN open2027
Comparison of Two Partially Covered Metal Stents for Endoscopic Ultrasound-guided Hepaticogastrostomy: A Multi-Center Retrospective Study.
Article in DEN open, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) is an alternative biliary drainage method after failed endoscopic retrograde cholangiopancreatography. Nevertheless, it is associated with adverse events (AEs), including peritonitis and stent migration. The influence of metallic stent (MS) design characteristics, including axial force (AF), on the safety and efficacy of EUS-HGS remains unclear. Methods: This multicenter retrospective study included patients with unresectable malignant biliary obstruction who underwent EUS-HGS using either a high-AF MS (Niti-S biliary S-type) or a low-AF MS (EGIS biliary) between January 2019 and December 2022. Propensity score matching was performed in a 1:2 ratio. Outcomes included clinical success, early and late non-recurrent biliary obstruction (non-RBO) AEs, RBO, time to RBO (TRBO), and overall survival (OS). Results: After matching, 27 patients in the high-AF group and 54 in the low-AF group were analyzed. Clinical success, RBO rate, TRBO, OS, and late non-RBO AE rates were similar between groups. However, early non-RBO AEs were more frequent in the high-AF group (37% vs. 13%, Conclusions: Of the two partially covered MSs evaluated, the EGIS biliary stent demonstrated fewer early non-RBO AEs after EUS-HGS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.